Crystal structure of Mycobacterium tuberculosis catalase-peroxidase

被引:159
作者
Bertrand, T
Eady, NAJ
Jones, JN
Nagy, JM
Jamart-Grégoire, B
Raven, EL
Brown, KA
机构
[1] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, Dept Biol Sci, London SW7 2AZ, England
[2] Ecole Natl Super Ind Chim, Inst Natl Polytech Lorraine, Lab Chim Phys Macromol, CNRS,UMR 7568, F-54001 Nancy, France
[3] Univ Leicester, Dept Chem, Leicester LE1 7RH, Leics, England
关键词
D O I
10.1074/jbc.M402382200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Mycobacterium tuberculosis catalase-peroxidase is a multifunctional heme-dependent enzyme that activates the core anti-tuberculosis drug isoniazid. Numerous studies have been undertaken to elucidate the enzyme-dependent mechanism of isoniazid activation, and it is well documented that mutations that reduce activity or inactivate the catalase-peroxidase lead to increased levels of isoniazid resistance in M. tuberculosis. Interpretation of the catalytic activities and the effects of mutations upon the action of the enzyme to date have been limited due to the lack of a three-dimensional structure for this enzyme. In order to provide a more accurate model of the three-dimensional structure of the M. tuberculosis catalase-peroxidase, we have crystallized the enzyme and now report its crystal structure refined to 2.4-Angstrom resolution. The structure reveals new information about dimer assembly and provides information about the location of residues that may play a role in catalysis including candidates for protein-based radical formation. Modeling and computational studies suggest that the binding site for isoniazid is located near the delta-meso heme edge rather than in a surface loop structure as currently proposed. The availability of a crystal structure for the M. tuberculosis catalase-peroxidase also permits structural and functional effects of mutations implicated in causing elevated levels of isoniazid resistance in clinical isolates to be interpreted with improved confidence.
引用
收藏
页码:38991 / 38999
页数:9
相关论文
共 90 条
[51]   Binding of catalase-peroxidase-activated isoniazid to wild-type and mutant Mycobacterium tuberculosis enoyl-ACP reductases [J].
Quemard, A ;
Dessen, A ;
Sugantino, M ;
Jacobs, WR ;
Sacchettini, JC ;
Blanchard, JS .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (06) :1561-1562
[52]  
Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002
[53]   Understanding functional diversity and substrate specificity in haem peroxidases: what can we learn from ascorbate peroxidase? [J].
Raven, EL .
NATURAL PRODUCT REPORTS, 2003, 20 (04) :367-381
[54]   The isoniazid-NAD adduct is a slow, tight-binding inhibitor of InhA, the Mycobacterium tuberculosis enoyl reductase:: Adduct affinity and drug resistance [J].
Rawat, R ;
Whitty, A ;
Tonge, PJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (24) :13881-13886
[55]   Effect of distal cavity mutations on the formation of compound I in catalase-peroxidases [J].
Regelsberger, G ;
Jakopitsch, C ;
Rüker, F ;
Krois, D ;
Peschek, GA ;
Obinger, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (30) :22854-22861
[56]   Spectral and kinetic studies of the oxidation of monosubstituted phenols and anilines by recombinant Synechocystis catalase -: Peroxidase compound I [J].
Regelsberger, G ;
Jakopitsch, C ;
Engleder, M ;
Rüker, F ;
Peschek, GA ;
Obinger, C .
BIOCHEMISTRY, 1999, 38 (32) :10480-10488
[57]   CHARACTERIZATION OF THE KATG AND INHA GENES OF ISONIAZID-RESISTANT CLINICAL ISOLATES OF MYCOBACTERIUM-TUBERCULOSIS [J].
ROUSE, DA ;
LI, ZM ;
BAI, GH ;
MORRIS, SL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (11) :2472-2477
[58]   MOLECULAR MECHANISMS OF ISONIAZID RESISTANCE IN MYCOBACTERIUM-TUBERCULOSIS AND MYCOBACTERIUM-BOVIS [J].
ROUSE, DA ;
MORRIS, SL .
INFECTION AND IMMUNITY, 1995, 63 (04) :1427-1433
[59]   Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis [J].
Rozwarski, DA ;
Grant, GA ;
Barton, DHR ;
Jacobs, WR ;
Sacchettini, JC .
SCIENCE, 1998, 279 (5347) :98-102
[60]   Use of site-directed mutagenesis to probe the structure, function and isoniazid activation of the catalase/peroxidase, KatG, from Mycobacterium tuberculosis [J].
Saint-Joanis, B ;
Souchon, H ;
Wilming, M ;
Johnsson, K ;
Alzari, PM ;
Cole, ST .
BIOCHEMICAL JOURNAL, 1999, 338 :753-760